19th Annual New York Lung Cancers Symposium
Participants will hear thought leaders from the New York area discuss optimal approaches for early-stage and locally advanced disease, as well as present the latest data on immunotherapy and targeted agents in metastatic lung cancers. These multidisciplinary interactions will be illustrated in a tumor board format, which will also allow participants to present questions and clinical challenges from their practice.